发明授权
US06632836B1 Carbocyclic potassium channel inhibitors 失效
碳环钾通道抑制剂

Carbocyclic potassium channel inhibitors
摘要:
The present invention relates to a class of carbocyclic compounds of Formula I that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like.
信息查询
0/0